Retail pharmacy operators face an array of challenges beyond PBM reform. “Drug stores need to identify a compelling and integrated new brand marketing proposition that brings together these changes to ...

“While we support affordable health care, the price controls that we are challenging would reduce access to new medicines that Americans are counting on, and would set a devastating precedent for all ...

“There is no protected property interest in selling goods to Medicare beneficiaries…at a price higher than what the government is willing to pay when it reimburses those costs.” – District Court for ...

It was another swing and a miss for the biopharma industry on Thursday, when a federal appeals court in Philadelphia unanimously rejected (PDF) a challenge by Novartis on the legality of the Inflation ...